Sandoz enters into agreement with Bio-Thera Solutions for Bevacizumab EP News Bureau Sep 9, 2021 Bevacizumab is a recombinant humanised monoclonal IgG1 antibody that targets vascular endothelial growth factor (VEGF), a key…
